Revolut: liquidity that outran the regulator

The situation

Revolut, the UK-based neobank, spent years waiting on a full UK banking licence — a significant overhang for a company built on financial services. Regulatory uncertainty like this often chills investor appetite, and by extension liquidity options, because buyers price in the risk that a core piece of the business model stalls. Despite that, employee demand for liquidity hadn't gone away.

How the deal worked

In 2024, Revolut ran a secondary share sale that let current and former employees sell stock to a group of investors, reported to value the company at roughly $45 billion — up sharply from its prior mark near $33 billion and making it one of the most valuable private fintechs in the world at the time, ahead of receiving its UK licence (which followed later that year). The buyers were largely existing institutional investors adding to their positions rather than new entrants, a common pattern in employee-only secondary sales where the company wants to control who becomes a shareholder.

The outcome

Employees got liquidity and a valuation mark ahead of, not after, the regulatory resolution investors had been waiting on — a bet by participating investors that the licence would eventually come through, which it did. The sale also functioned as a public confidence signal at a moment when headlines were focused on Revolut's regulatory delays rather than its growth.

What it teaches

A pending regulatory or legal overhang doesn't have to freeze secondary activity — it changes who is willing to transact and at what price. Investors with conviction on the eventual outcome can use a secondary sale to build a position ahead of a catalyst, while sellers get certainty now instead of waiting for resolution.